Vanguard Discloses 14.2% Stake in Orthofix Medical Inc.
Ticker: OFIX · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 884624
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, medical-devices
TL;DR
**Vanguard still owns a big chunk of Orthofix, holding 14.2% as of Dec 29, 2023.**
AI Summary
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Orthofix Medical Inc. As of December 29, 2023, Vanguard reported beneficial ownership of 3,099,697 shares of Orthofix Common Stock, representing 14.2% of the company. This is an update to their previous filing, indicating a change in their holdings and reinforcing Vanguard's significant stake in Orthofix. For investors, this means a large institutional investor maintains a substantial position, which can signal confidence but also means any future large sales by Vanguard could impact the stock price.
Why It Matters
This filing shows that a major institutional investor, The Vanguard Group, holds a significant portion of Orthofix Medical Inc. stock, which can influence market perception and stock stability.
Risk Assessment
Risk Level: low — The filing indicates a stable, significant institutional ownership, which generally reduces volatility risk for the stock.
Analyst Insight
Investors should note Vanguard's continued significant ownership, which suggests long-term institutional interest. Monitor future 13G/A filings for any substantial changes in Vanguard's position, as large sales could put downward pressure on the stock.
Key Numbers
- 3,099,697 — Shares Beneficially Owned (The total number of Orthofix Medical Inc. Common Stock shares held by The Vanguard Group as of December 29, 2023.)
- 14.2% — Percentage of Class (The percentage of Orthofix Medical Inc.'s Common Stock that The Vanguard Group beneficially owns.)
Key Players & Entities
- The Vanguard Group (company) — reporting person and institutional investor
- Orthofix Medical Inc. (company) — subject company whose securities are being reported
- 3,099,697 shares (dollar_amount) — total number of shares beneficially owned by Vanguard
- 14.2% (dollar_amount) — percentage of Orthofix Medical Inc. Common Stock beneficially owned by Vanguard
- December 29, 2023 (date) — date of the event which required the filing of this statement
Forward-Looking Statements
- Vanguard will maintain a significant stake in Orthofix Medical Inc. (The Vanguard Group) — medium confidence, target: Next 12 months
FAQ
Who filed this SC 13G/A amendment?
The Vanguard Group, a company based in Pennsylvania with IRS Identification No. 23-1945930, filed this SC 13G/A amendment.
What company's stock is the subject of this filing?
The subject company is Orthofix Medical Inc., with CIK 0000884624, located at 3451 Plano Parkway, Lewisville, TX.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 29, 2023.
How many shares of Orthofix Medical Inc. Common Stock does Vanguard beneficially own?
As of December 29, 2023, The Vanguard Group beneficially owns 3,099,697 shares of Orthofix Medical Inc. Common Stock.
What percentage of Orthofix Medical Inc.'s Common Stock does Vanguard own?
The Vanguard Group beneficially owns 14.2% of Orthofix Medical Inc.'s Common Stock.
Filing Stats: 808 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-02-13 17:12:22
Filing Documents
- tv01631-orthofixmedicalinc.htm (SC 13G/A) — 11KB
- 0001104659-24-021645.txt ( ) — 13KB
(a) - Name of Issuer
Item 1(a) - Name of Issuer: Orthofix Medical Inc
(b) - Address of Issuer's Principal Executive Offices
Item 1(b) - Address of Issuer's Principal Executive Offices: 3451 Plano Parkway Lewisville, TX 75056
(a) - Name of Person Filing
Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930
(b) – Address of Principal Business Office or, if none, residence
Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355
(c) – Citizenship
Item 2(c) – Citizenship: Pennsylvania
(d) - Title of Class of Securities
Item 2(d) - Title of Class of Securities: Common Stock
(e) - CUSIP Number
Item 2(e) - CUSIP Number 68752M108
- Type of Filing
Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).
- Ownership
Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.
- Ownership of Five Percent or Less of a Class
Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following
- Ownership of More Than Five Percent on Behalf of Another Person
Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable
- Identification and Classification of Members of Group
Item 8 - Identification and Classification of Members of Group: Not applicable
- Notice of Dissolution of Group
Item 9 - Notice of Dissolution of Group: Not applicable
- Certification
Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration